Related Experiment Video
Updated: Jan 21, 2026

Bilateral Assessment of the Corticospinal Pathways of the Ankle Muscles Using Navigated Transcranial Magnetic Stimulation
Published on: February 19, 2019
Exteroceptive suppression of voluntary activity in thenar muscles by cutaneous stimulation: How many trials should be
Dobrivoje S Stokic1, Markus Kofler2, Ivana Stetkarova3
1Center for Neuroscience and Neurological Recovery, Methodist Rehabilitation Center, Jackson, MS, USA.
Objective:
To determine a minimum number of trials that preserve input-output (I-O) properties of duration and magnitude of exteroceptive EMG suppression (eEMGs).
Patients And Methods:
eEMGs was recorded in 16 healthy subjects from thenar muscles following index finger stimulation at 2.5, 5, 10, and 20 times sensory threshold (xST). Individual trials were rectified and incrementally averaged in blocks of 5, 10, 20, 30, 40, 50, and 60. To determine if the block size affects I-O properties, the goodness of curve fit parameter R2 for each block was compared to R2 of the global function across all blocks combined.
Results:
eEMGs was found in all subjects at 10xST and 20xST (100%, respectively) but less often at 5xST (63-75%) and 2.5xST (25-56%). A quadratic function best described both duration and magnitude of eEMGs. The quadratic R2 did not significantly differ between any individual block function (5-60) and the global function (eEMGs duration 0.647-0.704 vs 0.679; magnitude 0.525-0.602 vs 0.560, respectively).
Conclusions:
Averaging 5 trials consistently shows eEMGs at and above 10xST. I-O properties of eEMGs do not differ whether 5 or up to 60 trials are averaged. Clinical studies of eEMGs in thenar muscles are possible with as few as 5 trials averaged.
More Related Videos
Related Concept Videos
Muscle Stimulation Frequency
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
Average Acceleration
Average Power
Average Velocity
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview

